NCT07252362 LCMS-Based Metabolic Analysis Explores the Effect of American Ginseng on Urine and Plasma in Healthy Individuals
| NCT ID | NCT07252362 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zhejiang Cancer Hospital |
| Condition | The Impact of American Ginseng on the Metabolomics of Urine and Plasma in Healthy Individuals |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2023-11-11 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2023-11-11 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Researchers will use LCMS Metabolic Analysis to Explore the Effect of American Ginseng on Urine and Plasma in Healthy Individuals Participants will: * Take 3 grams of American Ginseng powder every day for 14 days * Collect the fasting urine samples at the following times at the hospital: On the first day, on the 7th day after taking the medicine, and on the 14th day after taking the medicine. * Collect the fasting Serum samples at the following times at the hospital: On the first day and on the 14th day after taking the medicine. * Have their any adverse effects monitored and evaluated throughout the study.
Eligibility Criteria
* 18 to 45 years old; * The subjects were fully informed about the research process and signed the informed consent form (the subjects had no abnormalities in routine physical examinations, no previous medical history, and no history of drug allergies); ③ During the trial, they were required to have a light diet and were prohibited from consuming alcoholic and caffeinated beverages;
Contact & Investigator
guan ai Bao, Master
STUDY DIRECTOR
Zhejiang Cancer Hospital
Frequently Asked Questions
Who can join the NCT07252362 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying The Impact of American Ginseng on the Metabolomics of Urine and Plasma in Healthy Individuals. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07252362 currently recruiting?
Yes, NCT07252362 is actively recruiting participants. Contact the research team at doctorbga@126.com for enrollment information.
Where is the NCT07252362 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT07252362 clinical trial?
NCT07252362 is sponsored by Zhejiang Cancer Hospital. The principal investigator is guan ai Bao, Master at Zhejiang Cancer Hospital. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.